TVARDI THERAPEUTICS, INC. Contractual Obligation, to be Paid, Year Four
TVARDI THERAPEUTICS, INC. (TVRD) had Contractual Obligation, to be Paid, Year Four of $1.69 million as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity › Contractual Obligation, to be Paid, Year Four and Five
us-gaap:ContractualObligationDueInFourthYear · last filed 2014-11-10
- 2014-09-30: Contractual Obligation, to be Paid, Year Four $1.69M.
- 2014-06-30: Contractual Obligation, to be Paid, Year Four $1.69M.
- 2014-03-31: Contractual Obligation, to be Paid, Year Four $1.69M.
| Period end | Contractual Obligation, to be Paid, Year Four |
|---|---|
| 2014-09-30 | $1.69M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.69M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.69M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |